Sangamo Therapeutics
SGMO
SGMO
187 hedge funds and large institutions have $370M invested in Sangamo Therapeutics in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 73 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 21
19% less capital invested
Capital invested by funds: $458M → $370M (-$87.4M)
Holders
187
Holding in Top 10
–
Calls
$2.56M
Puts
$1.54M
Top Buyers
| 1 | +$8.44M | |
| 2 | +$7.52M | |
| 3 | +$5.75M | |
| 4 |
CC
Casdin Capital
New York
|
+$4.14M |
| 5 |
BlackRock
New York
|
+$3.11M |
Top Sellers
| 1 | -$3.04M | |
| 2 | -$1.47M | |
| 3 | -$1.16M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.09M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$875K |